This is the authors' abstract. We don't add key points for this paper.
Treatment with insulin glargine and glulisine resulted in significant improvement in glycemic control compared with that achieved with the use of SSI alone. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the management of non-critically ill, hospitalized patients with type 2 diabetes.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Umpierrez et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: